Pfizer scraps cholesterol drug
The heart of Pfizer's business took a major blow when it was forced to halt development on their most promising cholesterol drug.
Archives for December 4, 2006
Rockwood sheds Groupe Novasep in €425m deal
Rockwood Holdings announced last week that it has reached an agreement to sell its subsidiary Groupe Novasep to a consortium of buyers in a transaction valued at €425m.
Evotec focuses on drug discovery with sale of technologies division to PE
Evotec AG has sold its cell analysis instrument division, Evotech Technologies, to PerkinElmer to allow it to focus more keenly on its drug discovery pipeline and drug discovery services divisions.
France to make personalised medicine a reality?
France has placed itself firmly at the forefront of research into personalised medical solutions for cancer, infectious diseases and rare genetic diseases by investing nearly half a billion euros into the ADNA project.
Cardinal divests drug manufacturing unit
Cardinal Health, the leading contract manufacturer for the pharmaceutical industry, has announced its plans to sell its drug manufacturing and packaging unit in order to focus on its health-care business.
Flu vaccine capacity at its highest… for now
Pharmaceutical giants push their flu vaccine production capacity to the limit but will it have an effect on future supply?
Demand for high visibility packaging on the rise
A US research company has published a report placing clamshell style packaging as the forerunner in the burgeoning high visibility packaging industry, with blister packs also on the increase.
Cross discipline approach could lead to tailored cancer drugs
A new cross-disciplinary collaboration could lead to cancer treatments designed specifically for individual patients.
Bioxel reaches Europe with taxane-based drug
Canadian pharma manufacturer Bioxel has announced it has received several orders for its paclitaxel product - a taxane-based drug effective to treat cancer - from two European customers representing a total of CAD$630,000 (€420,000).